HOOKIPA Pharma Inc. (NASDAQ: HOOK)
$6.47
+0.5500 ( +9.29% ) 98.7K
HOOKIPA Pharma Inc is a clinical stage biopharmaceutical company developing a class of immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform that is designed to reprogram the body's immune system. It uses off-the-shelf technologies, VaxWave and TheraT, to elicit directly within patients a response of antigen-specific killer T cells and antibodies.
Market Data
Open
$6.47
Previous close
$5.92
Volume
98.7K
Market cap
$65.31M
Day range
$5.87 - $6.62
52 week range
$4.10 - $11.30
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
8-k | 8K-related | 14 | Jul 10, 2024 |
8-k | 8K-related | 14 | Jun 18, 2024 |
4 | Insider transactions | 1 | Jun 18, 2024 |
4 | Insider transactions | 1 | Jun 18, 2024 |
4 | Insider transactions | 1 | Jun 18, 2024 |
4 | Insider transactions | 1 | Jun 18, 2024 |
4 | Insider transactions | 1 | Jun 18, 2024 |
4 | Insider transactions | 1 | Jun 18, 2024 |
8-k | 8K-related | 15 | Jun 04, 2024 |
8-k | 8K-related | 15 | May 23, 2024 |